These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2241535)

  • 21. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 1. Choice of the optimal vehicle and determination of the physical parameters of the suppositories].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):295-302. PubMed ID: 1785358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro sodium salicylate release from a sucrose polyester matrix.
    Castellano PM; Pastoriza MA; Martińez de Bertorello M; Bertorello HE; Horas JA
    J Pharm Sci; 1989 Jul; 78(7):561-2. PubMed ID: 2778655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural studies on complexes. IV. Crystal structure of a 1:1 5-chlorosalicylic acid and theophylline complex.
    Shefter E
    J Pharm Sci; 1969 Jun; 58(6):710-4. PubMed ID: 5799760
    [No Abstract]   [Full Text] [Related]  

  • 24. Formulation and in vitro examination of furosemide containing suppositories and preliminary experiences of their clinical use.
    Regdon G; Fazekas T; Regdon G; Selmeczi B
    Pharmazie; 1996 Feb; 51(2):116-9. PubMed ID: 8720807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rectal absorption of phenobarbital in children as affected by different vehicles].
    Heimann G; Neuwald F; Gladtke E
    Arzneimittelforschung; 1978; 28(6):1023-6. PubMed ID: 581999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of excipients on tablet properties and dissolution behavior of theophylline-tableted microcapsules under different compression forces.
    Lin SY
    J Pharm Sci; 1988 Mar; 77(3):229-32. PubMed ID: 3373426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of diffusion rates of benzocaine from topical vehicles using sodium salicylate as complexing agent.
    York P; Saleh AA
    J Pharm Sci; 1976 Apr; 65(4):493-7. PubMed ID: 1271245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of method of preparation on pharmaceutical availability of aminophylline suppositories].
    Knapczyk J; Starosta B; Bitner J
    Folia Med Cracov; 1979; 21(1):149-56. PubMed ID: 396189
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of drug (core) particle size on the dissolution of theophylline from microspheres made from low molecular weight cellulose acetate propionate.
    Shukla AJ; Price JC
    Pharm Res; 1989 May; 6(5):418-21. PubMed ID: 2748534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH- and flow-rate-independent release of drug from uncoated slow-release tablets.
    Jambhekar SS; Cobby J
    J Pharm Sci; 1985 Sep; 74(9):991-4. PubMed ID: 4067855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 May; 47(5):355-9. PubMed ID: 7494182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method.
    McGinity JW; Maincent P; Steinfink H
    J Pharm Sci; 1984 Oct; 73(10):1441-4. PubMed ID: 6502495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current problems in the quality control of pharmaceutical preparations manufactured in pharmacies III. Investigation of theophilline containing suppositories].
    Takácsné NK; Sinkó B; Hang I; Kiss G; Dávid AZ; Horváth PE
    Acta Pharm Hung; 2007; 77(2):82-9. PubMed ID: 17933266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous flow bead-bed dissolution apparatus for suppositories.
    Roseman TJ; Derr GR; Nelson KG; Lieberman BL; Butler SS
    J Pharm Sci; 1981 Jun; 70(6):646-51. PubMed ID: 7252809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G; Vágó I; Mándi E; Regdon G; Erós I
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of solubility parameters of drug and vehicle to predict flux through skin.
    Sloan KB; Koch SA; Siver KG; Flowers FP
    J Invest Dermatol; 1986 Aug; 87(2):244-52. PubMed ID: 3734472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The content-uniformity of dispensary-prepared rectal suppositories].
    Lüdde H; Nestler D
    Pharmazie; 1990 Jan; 45(1):47-50. PubMed ID: 2333313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.